HealthQuest participates in $35.5M Series B financing for BardyDx

HealthQuest Capital, River Cities Capital Funds, Aperture Venture Partners, Aphelion Capital and others invested $35.M into BardyDx, a leading provider of ambulatory cardiac monitoring technologies and custom data solutions. The funds will be used to further accelerate growth of its innovative P-wave focused cardiac monitoring platform through expansion of BardyDx's sales force and monitoring services, and to support advanced development programs, including augmented intelligence and visualization technologies.

For more click here

Randy Scott